Russell Investments Group
GRTX

Russell Investments Group’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Russell Investments Group’s Portfolio GRTX Stock Details GRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-22,262
Closed -$196K – 3317
2021
Q1 		$196K Hold
22,262
– – ﹤0.01% 2839
2020
Q4 		$227K Hold
22,262
– – ﹤0.01% 2725
2020
Q3 		$201K Buy
+22,262
New +$176K ﹤0.01% 2776

Other funds holding GRTX

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Russell Investments Group's GRTX Position: Q2 2021 in Review

Russell Investments Group sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q2 2021, closing a stake of 22,262 shares — an estimated $196K sold.

Russell Investments Group first reported a position in GRTX in Q3 2020 and held it in 3 quarters. The position peaked at $227K in Q4 2020. 47 funds tracked by Wall St. Rank hold GRTX as of Q2 2021.

  • Russell Investments Group reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Russell Investments Group sold 22,262 Galera Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $196K.
  • Russell Investments Group first reported a position in Galera Therapeutics, Inc. Common Stock in Q3 2020 and held it in 3 quarters.
  • Russell Investments Group's Galera Therapeutics, Inc. Common Stock position peaked at $227K in Q4 2020.
  • 47 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q2 2021.

Based on Russell Investments Group's 13F filing for Q2 2021, filed 4 Aug 2021.